Taste and smell loss in patients with COVID-19
In the aftermath of COVID-19, the association between SARS-CoV-2 and chemosensory deficits have been well established. Taste and smell loss have been included in the official lists of symptoms worldwide, as it is a common symptom (and for some patients the only symptom) of COVID-19 as described in this review. Patients with COVID-19 often have combined taste and smell loss, have a milder clinical presentation, and are younger than previous patients with postviral olfactory loss. Patients should start olfactory training early and should be seen by an ear, nose and throat physician if they do not experience improvement of the senses within 12 weeks.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:182 |
|---|---|
| Enthalten in: |
Ugeskrift for laeger - 182(2020), 36 vom: 31. Aug. |
| Sprache: |
Dänisch |
|---|
| Beteiligte Personen: |
Fjældstad, Alexander W [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.10.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM315712112 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315712112 | ||
| 003 | DE-627 | ||
| 005 | 20231225155518.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||dan c | ||
| 028 | 5 | 2 | |a pubmed24n1052.xml |
| 035 | |a (DE-627)NLM315712112 | ||
| 035 | |a (NLM)33000727 | ||
| 035 | |a (PII)V06200442 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a dan | ||
| 100 | 1 | |a Fjældstad, Alexander W |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Taste and smell loss in patients with COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.10.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In the aftermath of COVID-19, the association between SARS-CoV-2 and chemosensory deficits have been well established. Taste and smell loss have been included in the official lists of symptoms worldwide, as it is a common symptom (and for some patients the only symptom) of COVID-19 as described in this review. Patients with COVID-19 often have combined taste and smell loss, have a milder clinical presentation, and are younger than previous patients with postviral olfactory loss. Patients should start olfactory training early and should be seen by an ear, nose and throat physician if they do not experience improvement of the senses within 12 weeks | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Ovesen, Therese |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 182(2020), 36 vom: 31. Aug. |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
| 773 | 1 | 8 | |g volume:182 |g year:2020 |g number:36 |g day:31 |g month:08 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 182 |j 2020 |e 36 |b 31 |c 08 | ||